You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 103 No. 11, November 1985 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLE
 This Article
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy. Two-year results of a randomized trial. Diabetic Retinopathy Vitrectomy Study report 2. The Diabetic Retinopathy Vitrectomy Study Research Group


Six hundred sixteen eyes with recent severe diabetic vitreous hemorrhage reducing visual acuity to 5/200 or less for at least one month were randomly assigned to either early vitrectomy or deferral of vitrectomy for one year. After two years of follow-up, 25% of the early vitrectomy group had visual acuity of 10/20 or better compared with 15% in the deferral group (P = .01). In patients with Type I diabetes, who were on the average younger and had more-severe proliferative retinopathy, there was a clear-cut advantage for early vitrectomy, as reflected in the percentage of eyes recovering visual acuity of 10/20 or better (36% vs 12% in the deferral group, P = .0001). No such advantage was found in the Type II diabetes group (16% in the early group vs 18% in the deferral group), but evidence that this advantage differed by diabetes type was of borderline significance.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Predictive clinical features and outcomes of vitrectomy for proliferative diabetic retinopathy
Yorston et al.
Br. J. Ophthalmol. 2008;92:365-368.
ABSTRACT | FULL TEXT  

Management of Diabetic Retinopathy: A Systematic Review
Mohamed et al.
JAMA 2007;298:902-916.
ABSTRACT | FULL TEXT  

Reduction of Diabetic Macular Edema by Oral Administration of the Kinase Inhibitor PKC412
Campochiaro
IOVS 2004;45:922-931.
ABSTRACT | FULL TEXT  

Diabetic Retinopathy
Frank
NEJM 2004;350:48-58.
FULL TEXT  

The Impact of Clinical Trials on the Treatment of Diabetes Mellitus
Nathan
J. Clin. Endocrinol. Metab. 2002;87:1929-1937.
ABSTRACT | FULL TEXT  

How Many Steps of Progression of Diabetic Retinopathy Are Meaningful?: The Wisconsin Epidemiologic Study of Diabetic Retinopathy
Klein et al.
Arch Ophthalmol 2001;119:547-553.
ABSTRACT | FULL TEXT  

Treatment of Diabetic Retinopathy
Ferris et al.
NEJM 1999;341:667-678.
FULL TEXT  

Practice Patterns in Diabetic Retinopathy: Part 1: Analysis of Retinopathy Follow-up
Khadem et al.
Arch Ophthalmol 1999;117:815-820.
ABSTRACT | FULL TEXT  

The CONSORT Statement: Will It Lead to Improved Reporting of Clinical Trials in Ophthalmology?
Hawkins
Arch Ophthalmol 1999;117:677-680.
FULL TEXT  

Prevention and Treatment of the Complications of Diabetes Mellitus
Clark and Lee
NEJM 1995;332:1210-1217.
FULL TEXT  

Long-Term Complications of Diabetes Mellitus
Nathan
NEJM 1993;328:1676-1685.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1985 American Medical Association. All Rights Reserved.